Focus: Rockwell Medical is a public biotechnology company specializing in dialysis products for nephrology patients, with a focused portfolio of iron management and mineral metabolism therapies. The company operates as a mid-cap dialysis specialist with ~$101M in annual revenue.
Profile data last refreshed 5h ago · AI intelligence enriched 3w ago
Rockwell Medical suits candidates seeking stability in a niche nephrology specialty and willing to accept limited growth roles; financial tightness and minimal hiring pose risks for ambitious career trajectory.
Help build intelligence for Rockwell Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Rockwell Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Lead NDA product facing loss of exclusivity in ~3 years; critical revenue cliff requiring pipeline replacement.
Generic ANDA product providing stable foundation revenue post-patent but facing commodity pricing pressure.
Original NDA formulation of ferric pyrophosphate; replacement by AVNU variant creates internal competition before patent expiry.
Rockwell Medical Inc (NASDAQ: RMTI) Share Price, RMTI Stock News, RMTI Share Price & Updates - Kalkine
Rockwell Medical Inc (NASDAQ: RMTI) Share Price, RMTI Stock News, RMTI Share Price & Updates Kalkine
Rockwell Medical (RMTI) Slips 2.58%: Key Support at $7.01 in Focus - Imbalance Zone - careplusvn.com
Rockwell Medical (RMTI) Slips 2.58%: Key Support at $7.01 in Focus - Imbalance Zone careplusvn.com
Rockwell Medical Inc (RMTI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Rockwell Medical Inc (RMTI) Risk Assessment: Volatility, Financial Risk & Investment Risk TradingKey
Rockwell Medical, Inc. (RMTI) stock price, news, quote and history - au.finance.yahoo.com
Rockwell Medical, Inc. (RMTI) stock price, news, quote and history au.finance.yahoo.com
Rockwell Medical outlines dialysis growth plans as a specialty pharmaceutical player - ad-hoc-news.de
Rockwell Medical outlines dialysis growth plans as a specialty pharmaceutical player ad-hoc-news.de
Rockwell Medical (RMTI) investors approve directors, pay, auditor and reverse stock split - Stock Titan
Rockwell Medical (RMTI) investors approve directors, pay, auditor and reverse stock split Stock Titan
Showing 6 of 10 news items
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Ethnicity evaluation of ferric pyrophosphate citrate among Asian and Non-Asian populations: a population pharmacokinetics analysis.
Ferric pyrophosphate citrate for parenteral administration of maintenance iron: structure, mechanism of action, clinical efficacy and safety.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo